Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria Transcript

PresentationThank you for standing by. Welcome to the Jasper Therapeutics Chronic Urticaria Data Update Webinar. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Jasper Investor Relations website following the conclusion of the event. I'd now like to hand the call over to Jasper's Head of Investor Relations, Alex Gray. Please go ahead, Alex.Alex Gray Thank you, Tara, and thank you to those listening in today. Joining us for the prepared remarks a ...